Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

September 9, 2022

FDA Issues Statement on New Cases of Rare Breast Implant-Related Cancers

Author(s):

Brielle Benyon

The Food and Drug Administration issued a statement about the incidence of new cases of rare cancers that have occurred in the scar tissue around breast implants.

The Food and Drug Administration (FDA) issued a statement informing the public about cancers — specifically squamous cell carcinoma and lymphomas — that may occur in the scar tissue around breast implants.

Of note, these cancers are not the same as the previously reported breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), according to the agency.

According to the Skin Cancer Foundation, squamous cell carcinoma is the second most common form of skin cancer.

The FDA reported being aware of fewer than 20 cases of squamous cell carcinoma and fewer than 30 cases of different lymphomas found in the scar tissue around implants, known as the capsule. As of Sept. 1, there have been a total of 22 medical device reports (which monitor and report on potential safety issues from medical devices) for breast implants: 10 related to squamous cell carcinoma, and 12 related to lymphomas.

The incidence rate and risk factors for breast implant-related cancers are currently unknown, according to the FDA.

“When breast implant information was provided, there have been literature reports of (squamous cell carcinoma) and various lymphomas in the capsule around the breast implants for both textured and smooth breast implants, and for both saline and silicone breast implants,” the FDA wrote in their report. “In some cases, people were diagnosed after years of having breast implants. Some of the reported signs and symptoms included swelling, pain, lumps or skin changes.”

Recommendations for Individuals With or Considering Breast Implants

The FDA recommended that people with breast implants, or those who are considering them should learn more about the potential risks.

Those who already have implants do not need to change their medical care, according to the agency, though they should monitor their implants and talk to their surgeons or health care team if they notice any changes. At this time, the FDA is not recommending the removal of implants for women without symptoms.

For women who experience issues or symptoms from their implants, the FDA urges them to file a report through MedWatch, which is the agency’s way of collecting data on side effects, which can potentially improve patient safety.

In the future, the FDA noted that it plans to complete a literature review of data and continue its partnership with the American Society of Plastic Surgeons to gather more information about cancers arising in the breast capsule. These findings will be communicated to the public.

“Right now, we do not have enough information to say whether breast implants cause these cancers or if some implants pose higher risks than others,” the FDA said in a statement. “For this reason, instances of (squamous cell carcinoma), lymphoma and any cancer located in the scar tissue around breast implants should be reported to the FDA.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Image of two doctors and text.
Image of two doctors with text.
Imiage of two doctors with text.
Image of patient and doctor.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Image of Dr. Evens.
Image of Dr. D'sa
Related Content
Advertisement
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice.
July 2nd 2025

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

Spencer Feldman
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Image of women with text.
June 25th 2025

June Breast Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy: © stock.adobe.com.
June 24th 2025

How a Blood Test May Help Guide Breast Cancer Treatment

Ryan Scott
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
June 24th 2025

What Breast Cancer Taught Me About Saying Yes to the Picture

Laura Yeager
After two bouts of breast cancer and a double mastectomy, I wish I had taken that photo at 34, just for me to remember the body I once had.
Related Content
Advertisement
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice.
July 2nd 2025

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

Spencer Feldman
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Image of women with text.
June 25th 2025

June Breast Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy: © stock.adobe.com.
June 24th 2025

How a Blood Test May Help Guide Breast Cancer Treatment

Ryan Scott
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
June 24th 2025

What Breast Cancer Taught Me About Saying Yes to the Picture

Laura Yeager
After two bouts of breast cancer and a double mastectomy, I wish I had taken that photo at 34, just for me to remember the body I once had.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.